ÈËÆÞÖгöÊÓƵ

Omar Wever-Pinzon
( out of 52 reviews )

Omar Wever-Pinzon, MD, FACC

Languages spoken: English, Spanish

Clinical Locations

Saint Alphonsus Regional Medical Center

Boise
208-367-4278

ÈËÆÞÖгöÊÓƵ of Utah Hospital

Heart Failure Clinic
Salt Lake City
801-585-5122

ÈËÆÞÖгöÊÓƵ of Utah Hospital

Heart Transplant Clinic
Salt Lake City
801-585-5122

Veterans Administration Medical Center

Salt Lake City
801-584-1235

  • Dr. Wever-Pinzon is an Associate Professor of Medicine and is the Cardiac Director, Hypertrophic Cardiomyopathy Program Center of Excellence. He received his medical degree from the ÈËÆÞÖгöÊÓƵ of Panama. Dr. Wever-Pinzon completed his Internal Medicine Residency, followed by a fellowship in Advanced Cardiac Imaging at St. Luke’s-Roosevelt Hospital Center-ÈËÆÞÖгöÊÓƵ Hospital of Columbia ÈËÆÞÖгöÊÓƵ College of Physicians and Surgeons in New York City. In 2010, he joined the Cardiology Investigator track at the ÈËÆÞÖгöÊÓƵ of Utah in Salt Lake City, where he completed his training in Cardiovascular Disease. In 2015, he completed his training in Advanced Heart Failure and Transplant Cardiology at the New York Presbyterian Hospital-Columbia ÈËÆÞÖгöÊÓƵ Medical Center in New York City.

    Dr. Wever-Pinzon's primary clinical and academic interests are focused on the development of the Hypertrophic Cardiomyopathy Program at the ÈËÆÞÖгöÊÓƵ of Utah. The goals of this program are to improve the clinical management of patients with this unique condition and to advance the understanding of this inherited cardiac disease through collaborative research efforts.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
    Educational Commission for Foreign Medical Graduates

    Patient Rating

    4.9 /5
    ( out of 52 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 22, 2024
    EXTERNAL SITE

    Spent adequate time listening to my health concerns, answering questions, and explaining treatment options. Was very respectful, empathetic, and knowledgeable.

    September 22, 2024
    EXTERNAL SITE

    Dr Omar has made feel that he does care about my health. I feel that he is and has done everything possible for me to maintain a good lifestyle. He listens to what I say and willingly answers my questions. He doesn't make feel like my appointment needs to be short so he can get out the door. This also goes for his assistant. They take the time needed to answer my questions. I cannot stress enough the confidence and faith that me and my family have in Dr Omar.

    July 26, 2024
    UH HOSPITALS AND CLINICS

    Dr. Wever Pinzon was extremly helpful and he took the time to explain to me all the details of my illness and the treatment he is prescribing. I felt very confortable.

    July 22, 2024
    UH HOSPITALS AND CLINICS

    Dr. Omar is the absolute berries!

    July 13, 2024
    UH HOSPITALS AND CLINICS

    Obviously the leader of a well run team of professionals.

    June 24, 2024
    UH HOSPITALS AND CLINICS

    He explained things well. I was offered new medication. I am more clear on my need for care and the path we are on to manage my condition.

    May 31, 2024
    EXTERNAL SITE

    Great job and knowledgeable. I trust my heart health to him

    March 13, 2024
    UH HOSPITALS AND CLINICS

    Dr. Omar was very helpful and friendly. He listened to my questions and addressed each one.

    March 13, 2024
    UH HOSPITALS AND CLINICS

    Outstanding provider

    See More Patient Comments

  • Dr. Wever-Pinzon is an Associate Professor of Medicine and is the Cardiac Director, Hypertrophic Cardiomyopathy Program Center of Excellence. He received his medical degree from the ÈËÆÞÖгöÊÓƵ of Panama. Dr. Wever-Pinzon completed his Internal Medicine Residency, followed by a fellowship in Advanced Cardiac Imaging at St. Luke’s-Roosevelt Hospital Center-ÈËÆÞÖгöÊÓƵ Hospital of Columbia ÈËÆÞÖгöÊÓƵ College of Physicians and Surgeons in New York City. In 2010, he joined the Cardiology Investigator track at the ÈËÆÞÖгöÊÓƵ of Utah in Salt Lake City, where he completed his training in Cardiovascular Disease. In 2015, he completed his training in Advanced Heart Failure and Transplant Cardiology at the New York Presbyterian Hospital-Columbia ÈËÆÞÖгöÊÓƵ Medical Center in New York City.

    Dr. Wever-Pinzon's primary clinical and academic interests are focused on the development of the Hypertrophic Cardiomyopathy Program at the ÈËÆÞÖгöÊÓƵ of Utah. The goals of this program are to improve the clinical management of patients with this unique condition and to advance the understanding of this inherited cardiac disease through collaborative research efforts.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Cardiovascular Medicine
    Board Certification
    American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
    Educational Commission for Foreign Medical Graduates

    Education history

    Postdoctoral Fellowship Vice President Clinical & Translational (VPCAT) Research Scholar Program - ÈËÆÞÖгöÊÓƵ of Utah Postdoctoral Scholar
    Advanced Heart Failure and Transplant Cardiology - New York Presbyterian Hospital-Columbia ÈËÆÞÖгöÊÓƵ Medical Center Advanced Fellow
    Research Fellow Mechanical Circulatory Support & Transplant - ÈËÆÞÖгöÊÓƵ of Utah Postdoctoral Fellow
    Cardiovascular Disease - ÈËÆÞÖгöÊÓƵ of Utah Fellow
    Fellowship Advanced Cardiac Imaging - St. Luke’s-Roosevelt Hospital Center, Columbia ÈËÆÞÖгöÊÓƵ College of Physicians & Surgeons Advanced Fellow
    Internal Medicine - St. Luke’s-Roosevelt Hospital Center, Columbia ÈËÆÞÖгöÊÓƵ College of Physicians & Surgeons Resident
    Internship Aquilino Tejeira Hospital Transitional Internship
    Hospital Santo Tomas Transitional Internship
    Professional Medical Medicine - Universidad de Panamá M.D.

    Selected Publications

    Journal Article

    1. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin S (2022). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424. ()
    2. Kim PJ, Olymbios M, Siu A, Wever Pinzon O, Adler E, Liang N, Swenerton R, Sternberg J, Kaur N, Ahmed E, Chen YA, Fehringer G, Demko ZP, Billings PR, Stehlik J (2022). A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation. J Heart Lung Transplant, 41(7), 919-927. ()
    3. Kapelios CJ, Lund LH, Wever-Pinzon O, Selzman CH, Myers SL, Cantor RS, Stehlik J, Chamogeorgakis T, McKellar SH, Koliopoulou A, Alharethi R, Kfoury AG, Bonios M, Adamopoulos S, Gilbert EM, Fang JC, Kirklin JK, Drakos SG (2022). Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database. Circ Heart Fail, 15(6), e008706. ()
    4. Topkara VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, Takeda K, Takayama H, Selzman CH, Naka Y, Burkhoff D, Stehlik J, Farr MA, Fang JC, Uriel N, Drakos SG (2021). Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. J Am Coll Cardiol, 79(9), 900-913. ()
    5. Shah P, Yuzefpolskaya M, Hickey GW, Breathett K, Wever-Pinzon O, Khue-Ton V, Hiesinger W, Koehl D, Kirklin JK, Cantor RS, Jacobs JP, Habib RH, Pagani FD, Goldstein DJ (2022). Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device. Ann Thorac Surg. ()
    6. Sherrid MV, Swistel DG, Olivotto I, Pieroni M, Wever-Pinzon O, Riedy K, Bach RG, Husaini M, Cresci S, Reyentovich A, Massera D, Maron MS, Maron BJ, Kim B (2021). Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc, 10(20), e021141. ()
    7. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J (2022). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol, 6(8), 957-962. ()
    8. Shah P, Psotka M, Taleb I, Alharethi R, Shams MA, Wever-Pinzon O, Yin M, Latta F, Stehlik J, Fang JC, Diao G, Singh R, Ijaz N, Kyriakopoulos CP, Zhu W, May CW, Cooper LB, Desai SS, Selzman CH, Kfoury AG, Drakos SG (2021). Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages. Circ Heart Fail, 14(5), e007991. ()
    9. Marashly Q, Taleb I, Kyriakopoulos CP, Dranow E, Jones TL, Tandar A, Overton SD, Tonna JE, Stoddard K, Wever-Pinzon O, Kemeyou L, Koliopoulou AG, Shah KS, Nourian K, Richins TJ, Burnham TS, Welt FG, McKellar SH, Nativi-Nicolau J, Drakos SG (2021). Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score. Catheter Cardiovasc Interv, 98(7), 1275-1284. ()
    10. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J (2021). Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun, 12(1), 873. ()
    11. Taleb I, Wever-Pinzon J, Wang W, Koliopoulou A, Dranow E, Yu T, Yin L, McKellar SH, Stehlik J, Fang JC, Wever-Pinzon O, Selzman CH, Drakos SG (2019). Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. Heart Lung Circ, 29(8), 1226-1233. ()
    12. Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M, Kfoury AG, Wever-Pinzon O, Fang JC, Selzman CH, Chaudhuri D, Rutter J, Drakos SG (2020). The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Circulation, 142(3), 259-274. ()
    13. Ho CY, Mealiffe ME, Bach RG, Bhattacharya M, Choudhury L, Edelberg JM, Hegde SM, Jacoby D, Lakdawala NK, Lester SJ, Ma Y, Marian AJ, Nagueh SF, Owens A, Rader F, Saberi S, Sehnert AJ, Sherrid MV, Solomon SD, Wang A, Wever-Pinzon O, Wong TC, Heitner SB (2020). Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol, 75(21), 2649-2660. ()
    14. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2019). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC Heart Fail, 8(4), 302-312. ()
    15. Hydren JR, Kithas AC, Park SH, Wever-Pinzon O, Selzman CH, Perry W, Vargas CAS, Stehlik J, Drakos SG, Richardson RS (2019). Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. ASAIO J, 66(3), 291-299. ()
    16. Alvarez Villela M, Wever-Pinzon O, Parikh M, Deru K, Muhlestein JB, Anderson JL, Weaver LK (2020). Patterns of cardiac dysfunction after carbon monoxide poisoning. Undersea Hyperb Med, 47(3), 477-485. ()
    17. Pepin ME, Drakos S, Ha CM, Tristani-Firouzi M, Selzman CH, Fang JC, Wende AR, Wever-Pinzon O (2019). DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. Am J Physiol Heart Circ Physiol, 317(4), H674-H684. ()
    18. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant, 38(8), 858-869. ()
    19. Symons JD, Deeter L, Deeter N, Bonn T, Cho JM, Ferrin P, McCreath L, Diakos NA, Taleb I, Alharethi R, McKellar S, Wever-Pinzon O, Navankasattusas S, Selzman CH, Fang JC, Drakos SG (2019). Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. Circ Heart Fail, 12(8), e006085. ()
    20. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos SG (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support. Circ Heart Fail, 140(1), 98-100.
    21. Wever-Pinzon O, Fang JC (2019). Characterization of Sympathetic Innervation in Heart Failure With Preserved Ejection Fraction. J Card Fail, 25(4), 314-315.
    22. Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, Nativi-Nicolau J, Stehlik J, Reid BB, Koliopoulou A, Stoddard GJ, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2018). Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support. Circ Heart Fail, 11(11), e005267. ()
    23. Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik J (2018). Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy. Circ Heart Fail, 11(8), e004759. ()
    24. Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG (2017). Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study. Circ Cardiovasc Imaging, 11(4), e007117. ()
    25. Zuiga Cisneros J, Stehlik J, Selzman CH, Drakos SG, McKellar SH, Wever-Pinzon O (2017). Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation. Circ Heart Fail, 11(3), e004378. ()
    26. Catino AB, Ferrin P, Wever-Pinzon J, Horne BD, Wever-Pinzon O, Kfoury AG, McCreath L, Diakos NA, McKellar S, Koliopoulou A, Bonios MJ, Al-Sarie M, Taleb I, Dranow E, Fang JC, Drakos SG (2018). Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support. Eur J Heart Fail, 20(1), 164-174. ()
    27. Saidi A, Selzman CH, Ahmadjee A, Al-Sarie M, Snow GL, Wever-Pinzon O, Alharethi R, Reid B, Stehlik J, Kfoury AG, Bader F (2018). Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation. ASAIO J, 64(1), 38-42. ()
    28. Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, Selzman CH, Fang JC, Lund LH, Stehlik J (2017). Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant, 36(4), 407-417. ()
    29. Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos SG (2016). Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading. J Am Coll Cardiol, 68(16), 1741-1752. ()
    30. Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman CH (2016). Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. J Am Coll Cardiol, 68(14), 1540-53. ()
    31. Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J Heart Lung Transplant, 35(8), 1024-30. ()
    32. Al-Sarie M, Rauf A, Kfoury AG, Catino A, Wever-Pinzon J, Bonios M, Horne BD, Diakos NA, Wever-Pinzon O, McKellar SH, Kelkhoff A, McCreath L, Fang J, Stehlik J, Selzman CH, Drakos SG (2016). Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow. JACC Heart Fail, 4(7), 570-576. ()
    33. Wever-Pinzon O, Naka Y, Garan AR, Takeda K, Pan S, Takayama H, Mancini DM, Colombo P, Topkara VK (2016). National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States. J Heart Lung Transplant, 35(7), 884-92. ()
    34. Pan S, Aksut B, Wever-Pinzon OE, Rao SD, Levin AP, Garan AR, Fried JA, Takeda K, Hiroo T, Yuzefpolskaya M, Uriel N, Jorde UP, Mancini DM, Naka Y, Colombo PC, Topkara VK (2015). Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database. J Heart Lung Transplant, 34(12), 1624-9. ()
    35. Romero J, Husain SA, Holmes AA, Kelesidis I, Chavez P, Mojadidi MK, Levsky JM, Wever-Pinzon O, Taub C, Makani H, Travin MI, Pina IL, Garcia MJ (2015). Non-invasive assessment of low risk acute chest pain in the emergency department: A comparative meta-analysis of prospective studies. Int J Cardiol, 187, 565-80. ()
    36. Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW (2014). Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed, 27(11), 1378-86. ()
    37. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG (2014). Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery. J Am Coll Cardiol, 64(15), 1602-12. ()
    38. Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Pina IL, Kfoury AG, Garcia MJ, Stehlik J (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol, 63(19), 1992-2004. ()
    39. Romero J, Kahan J, Kelesidis I, Makani H, Wever-Pinzon O, Medina H, Garcia MJ (2013). CMR imaging for the evaluation of myocardial stunning after acute myocardial infarction: a meta-analysis of prospective trials. Eur Heart J Cardiovasc Imaging, 14(11), 1080-91. ()
    40. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol, 61(19), 1985-94. ()
    41. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F (2013). Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail, 6(3), 517-26. ()
    42. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62. ()
    43. Wever-Pinzon O, Suma V, Ahuja A, Romero J, Sareen N, Henry SA, De Benedetti Zunino M, Chaudhry FF, Suryadevara RS, Sherrid MV, Chaudhry FA (2012). Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study. Eur Heart J Cardiovasc Imaging, 13(10), 857-62. ()
    44. Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, Bangalore S (2012). Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol, 110(3), 383-91. ()
    45. Yao SS, Wever-Pinzon O, Zhang X, Bangalore S, Chaudhry FA (2012). Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease. Am J Cardiol, 109(2), 153-8. ()
    46. Wever-Pinzon O, Bangalore S, Romero J, Silva Enciso J, Chaudhry FA (2011). Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study. JACC Cardiovasc Imaging, 4(12), 1231-8. ()
    47. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61. ()
    48. Wever Pinzon O, Silva Enciso J, Romero J, Makani H, Fefer J, Gandhi V, Bangalore S, Chaudhry FA (2011). Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography. Circ Cardiovasc Imaging, 4(4), 363-70. ()
    49. Supariwala A, Uretsky S, Singh P, Memon S, Khokhar SS, Wever-Pinzon O, Atluri P, Hersh J, Koppuravuri HK, Rozanski A (2011). Synergistic effect of coronary artery disease risk factors on long-term survival in patients with normal exercise SPECT studies. J Nucl Cardiol, 18(2), 207-14; quiz 217. ()
    50. Makani H, Bangalore S, Romero J, Wever-Pinzon O, Messerli FH (2011). Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema. Am J Med, 124(2), 128-35. ()

    Review

    1. Tseliou E, Lavine KJ, Wever-Pinzon O, Topkara VK, Meyns B, Adachi I, Zimpfer D, Birks EJ, Burkhoff D, Drakos SG (2022). Biology of myocardial recovery in advanced heart failure with long-term mechanical support. [Review]. J Heart Lung Transplant, 41(10), 1309-1323. ()
    2. Wever-Pinzon O, Drakos SG, Fang JC (2015). Team-based Care for Advanced Heart Failure. [Review]. Heart Fail Clin, 11(3), 467-77. ()
    3. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012). Ventricular assist devices: pharmacological aspects of a mechanical therapy. [Review]. Pharmacol Ther, 134(2), 189-99. ()
    4. Movsesian M, Wever-Pinzon O, Vandeput F (2011). PDE3 inhibition in dilated cardiomyopathy. [Review]. Curr Opin Pharmacol, 11(6), 707-13. ()
    5. Wever-Pinzon OE, Myerson M, Sherrid MV (2009). Sudden cardiac death in young competitive athletes due to genetic cardiac abnormalities. [Review]. Anadolu Kardiyol Derg, 9 Suppl 2, 17-23. ()
    6. Sherrid MV, Wever-Pinzon O, Shah A, Chaudhry FA (2009). Reflections of inflections in hypertrophic cardiomyopathy. [Review]. J Am Coll Cardiol, 54(3), 212-9. ()

    Book Chapter

    1. Wever-Pinzon O, Fang JC (2016). Heart Failure. In S.C. McKean, J.J. Ross, D.D. Dressler, D. Schurer (Eds.), Principles and Practice of Hospital Medicine (2, pp. 941-953). NewYork, USA: McGraw Hill.
    2. Diakos NA, Wever-Pinzon O, Zannas AS, Drakos SG (2013). Mechanical Unloading and Heart Remodeling Features. In EA Gabriel & SA Gabriel (Eds.), Inflammatory Response in Cardiovascular Surgery (1, pp. 413-8). New York: Springer.
    3. Wever Pinzon O, Chaudhry FA (2011). Stress Echocardiography. In A.L. Klein & C.R. Asher (Eds.), Clinical Echocardiography Review: A self assessment tool (1, pp. 193-209). Baltimore: Lippincott Williams & Wilkins.

    Case Report

    1. Nativi-Nicolau J, Stehlik J, Kelkhoff AJ, Khong B, Truax CM, Revelo MP, Gilbert EM, Drakos S, Wever-Pinzon O, Fang J, Catino A, Khong HT (2022). Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report. Transplant Proc, 54(1), 193-196. ()
    2. Wever-Pinzon O, Givens RC, Flannery M, Naka Y, Jorde UP (2015). Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: the short-to-shield phenomenon. J Heart Lung Transplant, 34(2), 270-1. ()
    3. Wever-Pinzon O, Romero J, Cordova JP (2013). Dual chamber pacing relieves obstruction in Japanese-variant hypertrophic cardiomyopathy. Am J Ther, 20(5), 588-90. ()
    4. Bukharovich IF, Wever-Pinzon O, Shah A, Todd G, Chaudhry FA, Sherrid MV (2012). Arterial embolism caused by large mobile aortic thrombus in the absence of atherosclerosis, associated with iron deficiency anemia. Echocardiography, 29(3), 369-72. ()
    5. Wever-Pinzon O, Wever-Pinzon J, Tami L (2011). Recurrent Takotsubo cardiomyopathy presenting with different morphologic patterns. Int J Cardiol, 148(3), 379-81. ()
    6. Wever-Pinzon O, Tami L (2010). Takotsubo cardiomyopathy following a blood transfusion. Congest Heart Fail, 16(3), 129-31. ()

    Editorial

    1. Fang JC, Wever-Pinzon O (2022). Allograft Rejection Surveillance In Heart Transplantation: Is There a Better Way? Circulation, 145(25), 1825-1828. ()
    2. Hydren JR, Richardson RS, Wever-Pinzon O, Drakos SG (2019). The "double whammy" of a continuous-flow left ventricular assist device on von Willebrand factor. J Thorac Cardiovasc Surg, 159(3), 910-915. ()
    3. Stehlik J, Wever-Pinzon O (2017). The Heart Transplant Waiting List and the Interplay of Policy and Practice: In Search of Fairness.LID - e004657 [pii]LID - 10.1161/CIRCHEARTFAILURE.117.004657 [doi]. Circ Heart Fail, 10(12). ()
    4. Wever-Pinzon O, Drakos SG (2016). The Continuing Quest to Identify Ambulatory Patients With Advanced Heart Failure Who Benefit From Left Ventricular Assist Device Therapy. Circ Heart Fail, 9(11). ()
    5. Fang JC, Wever-Pinzon O (2016). Dealing With Unintended Consequences: Continuous-Flow LVADs and Aortic Insufficiency. JACC Cardiovasc Imaging, 9(6), 652-4. ()

    Letter

    1. Wever-Pinzon O, Jorde UP (2014). Early power elevations and adverse events with the HeartMate II left ventricular assist device: An unsettled issue. [Letter to the editor]. J Heart Lung Transplant, 33(11), 1200-1. ()
    2. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos SG (2013). Reply: left ventricular assist devices in chronic heart failure: more questions than answers? [Letter to the editor]. J Am Coll Cardiol, 62(23), 2257-8. ()

    Abstract

    1. Revelo M, Hammond EH, Stehlik J, Alharethi R, Reid B, Drakos S, Selzman C, Afshar K, Wever-Pinzon O, McKellar S, Kfoury AG, Miller DV (2017). Ultrastructural Alterations in Explanted Failed Cardiac Allografts: Insights into "Chronic Rejection" [Abstract]. J Heart Lung Transplant, 36(4), S446-447.
    2. Nativi-Nicolau J, Jaramillo Morales J, Whipple M, Al-Dulaimi R, Stehlik J, Ryan J, Drakos S, Gilbert EMM, Wever-Pinzon O, Wilson B, Han F, Maurer MS, Fang J (2016). Amyloidosis Cardiomyopathy Demonstrates Distinct Echocardiographic Patterns Compared to Patients with Heart Failure with Preserved Ejection Fraction. [Abstract]. J Card Failure, 22(8S), S50.
    3. Wever-Pinzon O, Drakos SG, McKellar SH, Koliopoulou A, Stehlik J, Selzman CH (2016). LVAD Explantation for Cardiac Recovery: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support. [Abstract]. J Heart Lung Transplant, 35(4), S11.
    4. Miller DV, Kfoury AG, Snow GL, Revelo M, Lal A, Stehlik J, McKellar SH, Fang JC, Caine W, Ashfar K, Drakos SG, Wever-Pinzon O, Molina KM, Hammond MH (2016). Histologic Features of Mixed Rejection in Heart Transplantation: More Than Just Cellular + Antibody-Mediated Rejection? [Abstract]. J Heart Lung Transplant, 35(4), S107.
    5. McCreath L, Drakos SG, Ferrin P, Diakos N, Navankasattusas S, Javan H, Budge D, McKellar SH, Caine WT, Wever-Pinzon O, Bonios M, Skedros K, Ragnhildstveit A, Afshar K, Li DY, Stehlik J, Kfoury AG, Selzman CH (2016). Association of Pre-Implant Inflammatory Profile and Functional Recovery with Chronic LVAD Unloading. J Heart Lung Transplant [Abstract]. J Heart Lung Transplant, 35(4), S11-12.
    6. Kang T, Ko B, Drakos SG, Stehlik J, Gilbert EM, Nativi-Nicolau J, Wever-Pinzon O, Fang JC, Koliopoulou A, Bott SI, Tonna JE, Selzman CH, McKellar SH (2016). Clinical Experience with Long-Distance Transportation of Patients on Acute Mechanical Circulatory Support Devices. [Abstract]. J Heart Lung Transplant, 35(4), S392-393.
    7. Diakos N, Navankasattusas S, McKellar SH, Kfoury AG, Ferrin P, McCreath L, Miller D, Wright S, Skedros K, Al-Sari M, Ragnhildstveit A, Wever-Pinzon O, Russel G, Koliopoulou A, Reid B, Stehlik J, Selzman CH, Drakos SG (2016). Changes in Metabolic Substrate Utilization and Pyruvate Mitochondrial Oxidation Mismatch during Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning. [Abstract]. J Heart Lung Transplant, 35(4), S56-57.
    8. Ferrin P, McCreath L, Diakos N, Navankasattusas S, Kfoury AG, Wever-Pinzon O, Al-Sarie M, Catino A, Bonios M, Alharethi R, Russell G, Ragnhildstveit A, Skedros K, Hammond EH, Li DY, Selzman CH, Caine W, Stehlik J, Drakos SG (2016). Relationship of Myocardial Fibrosis with the Potential of Mechanical Unloading to Induce Favorable Cardiac Structural and Functional Response. [Abstract]. J Heart Lung Transplant.
    9. Tabachnick D, Stehlik J, Gilbert E, Nativi-Nicolau J, Fang J, Wever-Pinzon O, Drakos S, Budge D, Kfoury B, Alharethi R, Caine W, Selzman C, McKellar S (2016). Characteristics and Co-Morbidities in Heart Transplant Recipients Who Survive into Their Eighties. [Abstract]. J Heart Lung Transplant, 35(4), S211.
    10. Ko B, Tandar A, Kang T, McKellar S, Stehlik J, Stoddard G, Morshedzadeh J, Koliopoulou A, Gilbert E, Nativi-Nicolau J, Wever-Pinzon O, Fang J, Selzman C, Welt F, Drakos S (2016). Role of a Multidisciplinary Shock Team in the Management of Cardiogenic Shock. [Abstract]. J Heart Lung Transplant, 35(4), S278-279.
    11. Wever-Pinzon O, Farr M, Naka Y, Takayama H, George I, Colombo P, Mancini D, Schulze P (2015). Effect of the 2006 U.S. Donor Heart Allocation Policy Change on Waitlist Complications and Post-Transplant Mortality Among Candidates Supported with Mechanical Circulatory Support. [Abstract]. J Heart Lung Transplant.
    12. Wever-Pinzon O, Levin AP, Fried J, Garan AR, Takeda K, Takayama H, Yuzefpolskaya M, Mancini D, Naka Y, Colombo P, Topkara VK (2015). Effect Of Device Thrombosis And Malfunction On Clinical Outcomes Of Patients Bridging With Continuous-Flow LVADs. [Abstract]. J Heart Lung Transplant.
    13. Biscotti M, Wever-Pinzon O, Yuzefpolskaya M, Takayama M, Naka Y, Rosenzweig EB, Bacchetta M (2015). Partial Pulmonary-Right heart Oxygenator (PROxy) Support System: A Novel Strategy for Management of Severe Pulmonary Hypertension [Abstract]. J Heart Lung Transplant.
    14. Levin AP, Fried J, Wever-Pinzon O, Garan AR, Takeda K, Takayama H, Yuzefpolskaya M, Jorde UP, Mancini DM, Naka Y, Colombo PC, Topkara VK (2015). Bridging to Transplant With Fully Implantable Biventricular Assist Devices vs. Total Artificial Heart Implantation in Patients With Advanced Biventricular Failure. [Abstract]. J Heart Lung Transplant.
    15. Fried J, Cagliostro B, Levin A, Wever-Pinzon O, Garan AR, Te-Frey R, Ronquillo KO, Takeda K, Takayama H, Yuzefpolskaya M, Mancini DM, Naka Y, Colombo PC, Topkara V (2015). Driveline Infection Is Not Associated With Increased Risk of Thrombotic Events in CF-LVAD Patients [Abstract]. J Heart Lung Transplant.
    16. Wever-Pinzon J, Al-Sarie M, Catino A, McCubrey R, Stehlik J, Kfoury A, Reid B, Wever-Pinzon O, Alharethi R, Wright S, Li D, Gilbert E, Mckellar S, Barney J, Fang J, Selzman C, Drakos S (2015). Structural and Functional Myocardial Improvement Following Continuous-Flow Mechanical Unloading in Chronic Ischemic and Non-Ischemic Cardiomyopathy. [Abstract]. J Heart Lung Transplant, 34(4), S126-127.
    17. Wever-Pinzon J, Wever-Pinzon O, Mckellar S, Badger C, Fang J, Drakos S, Gilbert E, Everitt M, Alharethi R, Budge D, Stehlik J, Kfoury A, Selzman C, Nativi-Nicolau J (2014). A Novel Model to Predict the Risk of Non-Surgical Bleeding Among Patients Receiving Continuous Flow Left Ventricular Assist Devices [Abstract]. J Heart Lung Transplant, 32(4S), S22.
    18. Willis C, Eckels D, Wever-Pinzon O, Kfoury A, Drakos SG, Alharethi R, Nativi Nicolau J, Budge D, Fang JC, Gilbert EM, Selzman CH, Stehlik J (2014). Do Continuous Flow Left Ventricular Assist Devices Really Cause Allosensitization? [Abstract]. J Heart Lung Transplant, 32(4S), S100.
    19. Diakos N, Yen C, Wever-Pinzon O, Selzman C, Reid B, Stehlik J, Koufry A, Alharethi R, Nativi J, Catino A, Davis C, Barney J, Wright S, Koliopoulou A, Fang J, Li D, Drakos S (2014). TNF as a Predictor of Myocardial Functional Improvement Induced By Left Ventricular Mechanical Unloading. [Abstract]. J Heart Lung Transplant.
    20. Diakos N, Barney J, Yen C, Stehlik J, Koufry A, Selzman C, Reid B, Wever-Pinzon O, Saidi A, Wright S, Koliopoulou A, Russell G, McCreath L, Fang J, Li D, Drakos S (2014). Structural Remodeling of the Cardiac Ventricles: When Left Isn’t Equally Right. [Abstract]. J Heart Lung Transplant.
    21. Galenko O, Kfoury AG, Yen C, Selzman CH, Stehlik J, Diakos N, Wever-Pinzon O, Reid BB, Peterson H, Knight S, Alharethi R, Budge D, Nativi-Nicolau J, McKellar S, Li DY, Carlquist JC, Drakos SG (2014). Circulating Levels of miR-15b and miR-133b in Patients during Chronic LVAD Unloading. [Abstract]. J Heart Lung Transplant.

    Other

    1. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J (2022). Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun (13(1), p. 7026). England. ()

  • News & Podcasts

    News